Robbin Nameki

Robbin Nameki, PhD, is a senior computational biologist specializing in immuno-oncology. Currently at Pfizer, Robbin supports drug candidates through critical transitions by analyzing and interpreting complex genomic datasets. Previously, Robbin served as a Doctoral Scientist at Cedars-Sinai, where they co-developed a novel statistical genetics pipeline and published extensive research in high-grade serous ovarian cancer. Robbin's academic background includes a PhD in Biology from Cedars-Sinai Medical Center and a Bachelor's degree in Biology from California State University, Long Beach. They also have experience mentoring students and leading initiatives within graduate education.